Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wathen KA et al. - The results were further confirmed by receiver operating characteristic analysis showing an area under the curve of 0.64 for endostatin to identify subsequent pre-eclampsia, and 0.71 in cases of severe pre-eclampsia. Optimal cut-off values were determined and used for calculations of sensitivity and specificity, which were 80 and 52% in pre-eclampsia, and 80 and 65% in the severe form of the disease. Conclusions. The concentrations of endostatin in maternal serum at 16-20 weeks' of gestation are associated with an increased risk of pre-eclampsia but not IUGR.

Related Articles

Maternal Circulating TNF-alpha Levels are Highly Correlated with IL-10 Levels, but not IL-6 and IL-8 Levels, in Women with Pre-Eclampsia
American Journal of Reproductive Immunology, 10/13/09    Relevance Score: 84%

Genetic polymorphisms in DNA repair gene APE1, XRCC1 and XPD and the risk of pre-eclampsia
European Journal of Obstetrics & Gynecology and Reproductive Biology, 10/09/09    Relevance Score: 84%

Parallel Decrease in Arterial Distensibility and in Endothelium-Dependent Dilatation in Young Women with a History of Pre-Eclampsia
Clinical and Experimental Hypertension, 11/18/09    Relevance Score: 82%

Soluble and Membranous Vascular Endothelial Growth Factor Receptor-2 in Pregnancies Complicated by Pre-Eclampsia
Yonsei Medical Journal, 10/29/09    Relevance Score: 82%

Preeclampsia and Risk of Developing Subsequent Diabetes
Hypertension in Pregnancy, 10/30/09    Relevance Score: 80%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address